Stocks of the Hour: Golden Deeps, Noxopharm, Echo IQ

Informed Investor09-03


Golden Deeps (ASX:GED) has announced that thick copper and zinc sulphide mineralisation has been intersected in diamond drilling of key targets at the Company’s Havilah Project. The results up to 18.5% Copper & 34.8% Zinc in initial pXRF readings. Shares are trading 157.14 per cent higher at 7.2 cents.

Innovative biotech company Noxopharm (ASX:NOX) has announced substantial progress on its Chroma™ technology platform, with encouraging brain cancer results plus early work on leukaemia. The Chroma drug development program focuses on generating promising novel anticancer drugs. Shares are trading 23.81 per cent higher at 13 cents.

Echo IQ  (ASX:EIQ) is pleased to provide the following overview of positive results from two recently completed clinical studies, which highlight the effectiveness of its AI-backed solution for heart failure when compared to an observed detection rate of 46% in clinical practice. Shares are trading 10 per cent higher at 16.5 cents.  
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment